Safety, tolerability and pharmacokinetics of multiple once-daily dosing of oral semaglutide in healthy males and in males with type 2 diabetes

被引：0

作者：

Granhall, C. ^{[1
]}

Donsmark, M. ^{[1
]}

Golor, G. ^{[2
]}

Sondergaard, F. L. ^{[1
]}

Thomsen, M. ^{[1
]}

机构：

[1] Novo Nordisk, Soborg, Denmark

[2] Parexel Int, Berlin, Germany

来源：

DIABETOLOGIA | 2017年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

790

引用

页码：S362 / S363

页数：2

共 50 条

[1] Safety, Tolerability, and Pharmacokinetics of Multiple Once-Daily Dosing of Oral Semaglutide in Healthy Males and in Males with T2D
Granhall, Charlotte
Donsmark, Morten
Golor, Georg
Sondergaard, Flemming L.
Thomsen, Mette
DIABETES, 2017, 66 : A318 - A318
[2] Safety, tolerability, pharmacokinetics and pharmacodynamics of once-daily oral doses of saxagliptin for 2 weeks in type 2 diabetic and healthy subjects
Boulton, David W.
Geraldes, Margarida
DIABETES, 2007, 56 : A161 - A161
[3] Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme
Thethi, Tina K.
Pratley, Richard
Meier, Juris J.
DIABETES OBESITY & METABOLISM, 2020, 22 (08): : 1263 - 1277
[4] Once-daily nevirapine dosing: a pharmacokinetics, efficacy and safety review
Cooper, C. L.
van Heeswijk, R. P. G.
HIV MEDICINE, 2007, 8 (01) : 1 - 7
[5] Safety, tolerability, and pharmacokinetics of once-daily trazodone extended-release caplets in healthy subjects
Karhu, D.
Gossen, E. R.
Mostert, A.
Cronje, T.
Fradette, C.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (12) : 730 - 743
[6] The safety and tolerability of once-daily IV-to-oral trovafloxacin
Reactions Weekly, 1999, 754 (1) : 3 - 3
[7] Safety, tolerability, and pharmacokinetics of single oral doses of BCH-10652 in healthy adult males
Smith, PF
Forrest, A
Ballow, CH
Martin, DE
Proulx, L
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) : 2816 - 2823
[8] Safety, tolerability and pharmacokinetics of a new inhaled once-daily phosphodiesterase (PDE) 4 inhibitor in healthy volunteers
Esposito, Oriana
Mariotti, Fabrizia
Acerbi, Daniela
Compagnoni, Anna
Nandeuil, Marie-Anna
EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[9] Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes
Dezii, CM
Kawabata, H
Tran, M
SOUTHERN MEDICAL JOURNAL, 2002, 95 (01) : 68 - 71
[10] Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal, healthy volunteers
Mallikaarjun, S
Salazar, DE
Bramer, SL
JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (02): : 179 - 187

← 1 2 3 4 5 →